Skip to main content

Legal

© CryoSave South Africa (Pty) Ltd
All rights reserved

January 24, 2024

Unlocking the Potential

Cord Blood Stem Cell Therapy and the Spectrum of Treatable Diseases

Dr. Lana du Plessis

Over the past three decades, the field of cord blood stem cell therapy has witnessed remarkable progress, with more than 40,000 successful transplants worldwide. These transplants have emerged as transformative treatments for various medical conditions, particularly blood disorders, inherited metabolic disorders, and immunodeficiency syndromes. As the therapeutic landscape continues to expand, cord blood stem cells have found applications in over 80 approved therapies, offering hope for patients facing a diverse range of diseases.

Treatable Diseases and Therapies

Cord blood stem cell transplants have proven effective in treating a multitude of diseases, ranging from blood cancers to inherited metabolic disorders and bone marrow disorders. The following is a glimpse into the scope of treatable diseases and approved therapies:

Blood Cancers:

  • Acute Lymphoblastic Leukaemia (ALL)
  • Acute Myeloid Leukaemia (AML)
  • Chronic Myeloid Leukaemia (CML)
  • Myelodysplastic Syndrome (MDS)
  • Multiple Myeloma
  • Hodgkin’s Lymphoma
  • Non-Hodgkin’s Lymphoma

Inherited Metabolic Disorders:

  • Hurler Disease (MPS type IH)
  • Osteopetrosis
  • Adrenoleukodystrophy
  • Krabbe Disease

Bone Marrow Disorders:

  • Aplastic Anaemia
  • Unspecified Fanconi Anaemia

Other Diseases:

  • Blood Disorders
  • Bone Marrow Failure Syndrome
  • Immunodeficiencies
  • Neuroblastoma
  • Solid Tumours

For a comprehensive list of current treatable diseases and therapies, interested readers can refer to the Parents’ Guide to Cord Blood.

Ongoing Clinical Trials

The frontier of cord blood stem cell therapy extends beyond approved therapies, with ongoing clinical trials exploring the potential applications of these cells in various conditions. Some of the areas currently under investigation include:

  • Acquired hearing loss
  • Alzheimer’s disease
  • Acute Ischemic Stroke
  • Autism Spectrum Disorders
  • Amyotropic Lateral Sclerosis
  • Bronchopulmonary dysplasia
  • Cartilage repair
  • Critical limb ischemia
  • Cerebral Palsy
  • Congenital Diaphragmatic Hernia
  • Congenital Heart Diseases
  • Childhood Hearing Loss
  • Corneal Epithelial Wounds
  • Ulcerative Colitis / Inflammatory Bowel Disease
  • Duchenne Muscular Dystrophy
  • Diabetic Foot Ulcers
  • Diabetes Mellitus (Type I & Type II)
  • Encephalopathy (neonatal)
  • Epidermolysis Bullosa
  • Fertility
  • Global development delay
  • Graft versus host diseases
  • Glaucoma
  • Hypoplastic left heart syndrome
  • HIV
  • Hydrocephalus
  • Ischemic Stroke (pre/peri-natal)
  • Intraventricular haemorrhage
  • Infant Lung Disease
  • Idiopathic Dilated Cardiomyopathy
  • In-Utero Brain Injury / Stroke
  • Liver Cirrhosis
  • Neurodegenerative Disorders
  • Preterm Neonatal Complications
  • Parkinson’s Disease
  • Rheumatoid Arthritis
  • Severe Hypoxic-ischemic Encephalopathy
  • Systemic Lupus Erythematosus
  • Spinal Cord Injury
  • Skin-Wound / Burns
  • Sweat Gland Diseases / Regeneration

References

  1. Cairo MS, Rocha V, Gluckman E, et al. Alternative allogeneic donor sources for transplantation for childhood diseases: unrelated cord blood and haploidentical family donora. Biol Blood Marrow Transplant. 2008; 14:44-53.
  2. Cairo MS, Tarek N, Lee DA, et al. Cellular engineering and therapy in combination with cord blood allografting in pediatric recipients. Bone Marrow Transplant. 2016;51:27-33
  3. Gluckman E, Ruggeri A, Rocha V, et al. for Eurocord, Netcord, World Marrow Donor Association and National Marrow Donor Program. Family-directed umbilical cord blood banking. Haematolgica. 2001; 96: 1700-1707.
  4. Mazonson P, Kane M, Colberg K, et al. Prevalence of medical conditions potentially amenable to cellular therapy among families privately storing umbilical cord blood. Matern Child Health J. 2016 (online).
  5. https://clinicaltrials.gov

Additional Articles


The AI-Stem Cell Alliance

June 25, 2025
the-ai-stem-cell-alliance
Artificial intelligence (AI) is rapidly transforming industries across the globe, but one of its most groundbreaking applications lies in the realm of regenerative medicine—specifically, stem cell therapy. The convergence of AI and stem cell science is opening new frontiers in personalized medicine, drug discovery, disease modeling, and cellular manufacturing, marking a new era in biotechnology. This article delves into how AI is optimizing the development, analysis, and clinical application of stem cell therapies, accelerating progress toward safer, more effective treatments.

Pioneering Men’s Health

June 2, 2025
The field of regenerative medicine has witnessed transformative advancements in recent years, particularly in the application of stem cell therapy for men’s health.

The Future of Hand Injury Recovery

May 2, 2025
To perform our daily tasks, to touch people, to gesture, to do your favourite hobby, to paint or draw a piece of art, to play guitar, to play piano…

Why do Stem Cell Banks charge Storage Fees?

April 24, 2025
Stem cell banks charge storage fees to ensure the long-term viability and security of stem cells.

Stem Cell Treatment in Sport’s Injury

March 24, 2025
Recent advancements in stem cell therapy have introduced innovative approaches to treating sports-related injuries, focusing on enhancing recovery and tissue regeneration.

Plastic Surgery and Stem Cells

March 24, 2025
The integration of stem cell therapy into plastic surgery has led to significant advancements, enhancing both reconstructive and aesthetic procedures.

The Future of Kidney Health

March 6, 2025
Recent breakthroughs in stem cell therapy offer new hope for treating kidney diseases, particularly chronic kidney disease (CKD) and acute kidney injury (AKI).

The Future of Glaucoma Treatment

March 6, 2025
Exciting breakthroughs in stem cell research are now opening doors to potential regenerative therapies that could restore vision in glaucoma patients.

A New Era in Hearing

March 3, 2025
While hearing aids and cochlear implants have long been the standard solutions, they do not address the root cause of hearing impairment.

Unlocking the Potential of Stem Cell Banking for ADHD Treatment

February 10, 2025
Recent advancements in regenerative medicine have opened new doors for treating neurodevelopmental disorders like autism spectrum disorder (ASD).